Home / Learn / Financial Advocacy / Financial Advocacy Guidelines

Financial Advocacy Guidelines

ACCC Financial Advocacy Services Guidelines

ACCC has developed the Financial Advocacy Services Guidelines to support the goal of proactively addressing financial issues along the cancer care continuum to help patients gain access to high-quality care for a better quality of life.

These guidelines have been developed with the input and guidance of the Advisory Committee for the ACCC Financial Advocacy Network and financial advocates working on the frontlines of care.

As the healthcare landscape continues to change and the role of oncology financial advocates evolves, ACCC offers these guidelines to assist programs in strengthening their financial advocacy services and to complement the resources available through the ACCC Financial Advocacy Network.
Download Your Copy

On-Demand Webinars

Access a summary of questions asked and answered during the live ACCC Financial Advocacy Services Town Hall webinar.
Financial Advocacy Guidelines Cover
begin-quoteI am excited about the possibilities we can offer our patients! I appreciate your guidance and efforts to help us navigate the financial paths for our patients.

Tricia V. Smith, CRCS
Special Program Financial Specialist
Inova Schar Cancer Institute  end-quote

From Oncology Issues

  • The Oncology Pharmacy Navigator
    By Kelly Rice, PharmD
    Patients with cancer experience a variety of difficulties in accessing and managing their medications. The Legacy Health Cancer Institute established an oncology pharmacy navigator to decrease barriers to patient access, reconcile medication lists, and alleviate the financial burden of cancer care.
  • Cost of Anti-Cancer Therapies Demands New Strategies for Decision-Making, Shared Responsibility, Communication
    By Amy Hindman
    As the price of new cancer treatments continues to rise, physicians in both the inpatient and outpatient settings need to factor cost as well as efficacy into treatment plans. Julie Kennerly-Shah, PharmD, MS, MHA, facilitates the Hematology Oncology Pharmacy and Therapeutics (P&T) Committee at The Ohio State University Comprehensive Cancer Center, determining which agents will be available to providers for treatment and if restrictions will be placed on those medications.
  • Implementation of Drug Vial Optimization to Reduce Drug Waste
    Lindsey B. Amerine, PharmD, MS, BCPS; Scott W. Savage, PharmD, MS; Erinn C. Rowe, PharmD, MS; Rowell Daniels, PharmD, MS, FASHP; John M. Valgus, PharmD, MHA, BCOP; Richard Redding, BA, CPHT; and Stephen F. Eckel, PharmD, MHA, BCPS
    In the Department of Pharmacy at the University of North Carolina North Carolina Cancer Hospital, discarding partial drug vials was a significant source of waste. With their Innovator Award–winning drug vial optimization program, the program maximized the lifespan of drugs within single-dose vials and realized an annual cost savings of more than $40 million.
  • Immuno-Oncology: Breaking Barriers, Exploring Solutions, Improving Patient Care
    The ACCC Immuno-Oncology Institute developed a multidisciplinary curriculum workshop bringing together faculty experienced in delivery of immunotherapy with cancer program staff in the earlier stages of IO integration. Over the past two years, these IO Visiting Experts Programs were hosted by ACCC Cancer Program Members nation-wide.
  •  Technology Unlocks Untapped Potential in a Financial Navigation Program
    By Clara Lambert, BBA, OPN-CG; Scott Legleitner, BA, LPhT, SST; and Kathleen LaRaia
    While financial navigation programs ease the burden of financial toxicity on patients with cancer and help healthcare organizations with revenue loss, the manual nature of the process is challenging for navigators and financial advocates. Cowell Family Cancer Center piloted a financial navigation software program to analyze the effects of automation on productivity, workflow, and organizational alignment.